Skin protection: New barrier cream protects without irritating

Las Vegas — A skin barrier protection cream (Tetrix, Coria Laboratories) appears to reduce exposure to skin allergens and irritants and decrease symptoms of eczematous dermatitis, according to James Q. Del Rosso, D.O., dermatology residency director, Valley Hospital Medical Center, Las Vegas.

Avoiding steroidal addiction: Consider calcineurin inhibitors first

Sheffield, England — New research data demonstrates that mild, moderate and potent strengths of topical corticosteroids (TCS) cause a thinning of the stratum corneum, particularly when applied for longer periods of time, whereas topical calcineurin inhibitors show no negative change in the integrity of the skin barrier.

Pediatric dermatitis: Efalizumab succeeds where standard treatments fail

Severe cases of atopic dermatitis can prove to be extremely challenging to effectively treat.

Where other therapies fail, efalizumab may be one therapeutic option that can ultimately serve as the "go-to" therapy for those cases where standard therapies fall short of the mark.

Corticosteroid lotion: Study addresses need for more pediatric clinical trials

An open-label study demonstrated the efficacy and safety of a four-week course of hydrocortisone butyrate lotion 0.1 percent (Locoid Lotion, Triax) for treating moderate-to-severe atopic dermatitis in pediatric patients ages 3 months to less than 18 years. Disease improvement was rapid and dramatic, and the safety evaluation included Cosyntropin Stimulation Testing.

Dermatitis flares: Consider contact sensitizers when treating eczema patients

Physicians should always consider contact sensitizers to be one of the causes of flaring atopic dermatitis, as well as those cases recalcitrant to therapy.

Trichloracetic acid: Unique technology can achieve superior cosmetic results

Many TCA peels are available on the market today but according to one expert, the Enerpeel with its unique technology can achieve superior cosmetic results and raises the bar in peeling treatments.

AAD: Severe pediatric skin disease

San Francisco — Children with skin diseases such as severe psoriasis, eczema and hemangiomas are benefiting from new treatments and new knowledge about existing treatments, experts say.

AAD: Recalcitrant AD in children

San Francisco — Most patients with atopic dermatitis (AD) will respond to conventional therapies, such as basic skincare and avoidance of prevocational factors; topical corticosteroids and calcineurin inhibitors; antibiotics for infection and oral antihistamines.

AAD: Gastrointestinal disease

San Francisco — Because the human body is an ecosystem rather than a sterilizable object, an expert says that gastrointestinal flora play a key role in mediating cutaneous manifestations of a variety of gastrointestinal ailments.